Fig. 5From: Healthy, mtDNA-mutationĀ free mesoangioblasts from mtDNA patients qualify for autologous therapyMitochondrial function. Mitochondrial respiration in MABs of tRNAleu mutation carriers was determined by measuring the oxygen consumption rate (OCR) in a Seahorse XF96 analyzer during treatment with oligomycin (oligo), FCCP and Antimycin/Rotenone (ant/rot), and corrected for cell number. Per cell line, 8 replicates were included; mean OCRāĀ±āS.D. is shown in figureBack to article page